{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:27:38Z","timestamp":1783110458946,"version":"3.54.6"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T00:00:00Z","timestamp":1237334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environ Health Prev Med"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s12199-008-0063-8","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T07:52:50Z","timestamp":1237276370000},"page":"216-222","source":"Crossref","is-referenced-by-count":19,"title":["Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases"],"prefix":"10.1007","volume":"14","author":[{"given":"Shuko","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumitsu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayasu","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takemi","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,18]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02897983","volume":"12","author":"T Otsuki","year":"2007","unstructured":"Otsuki T. Immunotoxicological researches and preventive medicine. Foreword\u2014the report from the 13th Annual Meeting of the Japanese Society of Immunotoxicology (JSIT 2006). Environ Health Prev Med. 2007;12:151\u20132.","journal-title":"Environ Health Prev Med"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02897984","volume":"12","author":"T Otsuki","year":"2007","unstructured":"Otsuki T, Miura Y, Maeda M, Hayashi H, Dong M, Nishimura Y. Keynote lecture in the 13th Japanese Society of Immunotoxicology (JSIT 2006)\u2014pathophysiological development and immunotoxicology: what we have found from the researches related to the silica and silicate such as asbestos. Environ Health Prev Med. 2007;12:153\u201364.","journal-title":"Environ Health Prev Med"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12199-007-0013-x","volume":"13","author":"T Otsuki","year":"2008","unstructured":"Otsuki T. Reviews of a symposium entitled \u201cmalignant mesothelioma\u201d organized by the Study Group on Fibrous and Particulate Substances of the 77th Annual Meeting of the Japanese Society of Hygiene, 2007. Environ Health Prev Med. 2008;13:53\u20134.","journal-title":"Environ Health Prev Med"},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12199-007-0012-y","volume":"13","author":"Y Miura","year":"2008","unstructured":"Miura Y, Nishimura Y, Maeda M, Murakami S, Hayashi H, Fukuoka K, et al. Immunological alterations found in mesothelioma patients and their experimental evidences. Environ Health Prev Med. 2008;13:55\u20139.","journal-title":"Environ Health Prev Med"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.envint.2008.01.003","volume":"34","author":"K Takahashi","year":"2008","unstructured":"Takahashi K, Otsuki T, Mase A, Kawado T, Kotani M, Ami K, et al. Negatively-charged air conditions and responses of the human psycho-neuro-endocrino-immune network. Environ Int. 2008;34:765\u201372.","journal-title":"Environ Int"},{"key":"63_CR6","unstructured":"Guidelines for the Use of the ILO International Classification of Radiographs of Pneumoconioses, Revised Edition 2000, ILO (International Labour Organization), Geneva, Switzerland."},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","volume":"294","author":"I Miyoshi","year":"1981","unstructured":"Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981;294:770\u20131.","journal-title":"Nature"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-3083.2005.01592.x","volume":"61","author":"F Hyodoh","year":"2005","unstructured":"Hyodoh F, Takata-Tomokuni A, Miura Y, Sakaguchi H, Hatayama T, Hatada S, et al. Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T cell line, MT-2, induced by an asbestos, chrysotile-A. Scand J Immunol. 2005;61:442\u20138.","journal-title":"Scand J Immunol"},{"key":"63_CR9","first-page":"261","volume":"4","author":"T Otsuki","year":"2007","unstructured":"Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M, et al. Immunological effects of silica and asbestos. Cell Mol Immunol. 2007;4:261\u20138.","journal-title":"Cell Mol Immunol"},{"key":"63_CR10","first-page":"11","volume":"2","author":"M Maeda","year":"2008","unstructured":"Maeda M, Miura Y, Nishimura Y, Murakami S, Hayashi H, Kumagai N, et al. Immunological changes in mesothelioma patients and their experimental detection. Clin Med Circ Resp Pulm Med. 2008;2:11\u20137.","journal-title":"Clin Med Circ Resp Pulm Med"},{"key":"63_CR11","first-page":"160","volume":"53","author":"U Saffiotti","year":"1998","unstructured":"Saffiotti U. Respiratory tract carcinogenesis by mineral fibres and dusts: models and mechanisms. Monaldi Arch Chest Dis. 1998;53:160\u20137.","journal-title":"Monaldi Arch Chest Dis"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0891-5849(92)90117-Y","volume":"12","author":"DW Kamp","year":"1992","unstructured":"Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med. 1992;12:293\u2013315.","journal-title":"Free Radic Biol Med"},{"key":"63_CR13","first-page":"1165","volume":"105S5","author":"AR Brody","year":"1997","unstructured":"Brody AR, Liu JY, Brass D, Corti M. Analyzing the genes and peptide growth factors expressed in lung cells in vivo consequent to asbestos exposure and in vitro. Environ Health Perspect. 1997;105S5:1165\u201371.","journal-title":"Environ Health Perspect"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jcb.240630509","volume":"24","author":"HI Pass","year":"1996","unstructured":"Pass HI, Mew DJ. In vitro and in vivo studies of mesothelioma. J Cell Biochem Suppl. 1996;24:142\u201351.","journal-title":"J Cell Biochem Suppl"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1547-4127(04)00111-2","volume":"14","author":"JJ Godleski","year":"2004","unstructured":"Godleski JJ. Role of asbestos in etiology of malignant pleural mesothelioma. Thorac Surg Clin. 2004;14:479\u201387.","journal-title":"Thorac Surg Clin"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s10495-006-9235-4","volume":"11","author":"Y Miura","year":"2006","unstructured":"Miura Y, Nishimura Y, Katsuyama H, Maeda M, Hayashi H, Dong M, et al. Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells. Apoptosis. 2006;11:1825\u201335.","journal-title":"Apoptosis"},{"key":"63_CR17","first-page":"5137","volume":"61","author":"S Alas","year":"2001","unstructured":"Alas S, Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin\u2019s lymphoma through inhibition of the interleukin 10 autocrine\/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res. 2001;61:5137\u201344.","journal-title":"Cancer Res"},{"key":"63_CR18","first-page":"316","volume":"9","author":"S Alas","year":"2003","unstructured":"Alas S, Bonavida B. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin\u2019s lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis. Clin Cancer Res. 2003;9:316\u201326.","journal-title":"Clin Cancer Res"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0065-2776(03)81008-8","volume":"81","author":"S Hori","year":"2003","unstructured":"Hori S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol. 2003;81:331\u201371.","journal-title":"Adv Immunol"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.autrev.2008.03.001","volume":"7","author":"N Askenasy","year":"2008","unstructured":"Askenasy N, Kaminitz A, Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev. 2008;7:370\u20135.","journal-title":"Autoimmun Rev"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","volume":"212","author":"MG Roncarolo","year":"2006","unstructured":"Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006;212:28\u201350.","journal-title":"Immunol Rev"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1440-1681.2006.04401.x","volume":"33","author":"H Liu","year":"2006","unstructured":"Liu H, Leung BP. CD4+CD25+ regulatory T cells in health and disease. Clin Exp Pharmacol Physiol. 2006;33:519\u201324.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"63_CR24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02967443","volume":"7","author":"J Kurebayashi","year":"2000","unstructured":"Kurebayashi J. Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications. Breast Cancer. 2000;7:124\u20139.","journal-title":"Breast Cancer"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1385\/CRIAI:28:3:187","volume":"28","author":"R Atreya","year":"2005","unstructured":"Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28:187\u201396.","journal-title":"Clin Rev Allergy Immunol"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","volume":"41","author":"DR Hodge","year":"2005","unstructured":"Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer. 2005;41:2502\u201312.","journal-title":"Eur J Cancer"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/thx.50.8.887","volume":"50","author":"JW Upham","year":"1995","unstructured":"Upham JW, Garlepp MJ, Musk AW, Robinson BW. Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches. Thorax. 1995;50:887\u201393.","journal-title":"Thorax"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1165\/ajrcmb.12.5.7742009","volume":"12","author":"DR Fitzpatrick","year":"1995","unstructured":"Fitzpatrick DR, Peroni DJ, Bielefeldt-Ohmann H. The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. Am J Respir Cell Mol Biol. 1995;12:455\u201360.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.1997.tb08332.x","volume":"110","author":"A Tomokuni","year":"1997","unstructured":"Tomokuni A, Aikoh T, Matsuki T, Isozaki Y, Otsuki T, Kita S, et al. Elevated soluble Fas\/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin Exp Immunol. 1997;110:303\u20139.","journal-title":"Clin Exp Immunol"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2567.1998.00509.x","volume":"94","author":"T Otsuki","year":"1998","unstructured":"Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Kawakami Y, et al. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology. 1998;94:258\u201362.","journal-title":"Immunology"},{"key":"63_CR31","first-page":"407","volume":"4","author":"T Otsuki","year":"1999","unstructured":"Otsuki T, Ichihara K, Tomokuni A, Sakaguchi H, Aikoh T, Matsuki T, et al. Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis. Int J Mol Med. 1999;4:407\u201311.","journal-title":"Int J Mol Med"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2249.1999.01083.x","volume":"118","author":"A Tomokuni","year":"1999","unstructured":"Tomokuni A, Otsuki T, Isozaki Y, Kita S, Ueki H, Kusaka M, et al. Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol. 1999;118:441\u20134.","journal-title":"Clin Exp Immunol"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-2478(00)00177-2","volume":"72","author":"T Otsuki","year":"2000","unstructured":"Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Isozaki Y, et al. Detection of alternatively spliced variant messages of Fas gene and mutational screening of Fas and Fas ligand coding regions in peripheral blood mononuclear cells derived from silicosis patients. Immunol Lett. 2000;72:137\u201343.","journal-title":"Immunol Lett"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/10408448209003370","volume":"10","author":"CL Uber","year":"1982","unstructured":"Uber CL, McReynolds RA. Immunotoxicology of silica. Crit Rev Toxicol. 1982;10:303\u201319.","journal-title":"Crit Rev Toxicol"},{"key":"63_CR35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajim.4700280505","volume":"28","author":"K Steenland","year":"1995","unstructured":"Steenland K, Goldsmith DF. Silica exposure and autoimmune diseases. Am J Ind Med. 1995;28:603\u20138.","journal-title":"Am J Ind Med"},{"key":"63_CR36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02788777","volume":"18","author":"DR Shanklin","year":"1998","unstructured":"Shanklin DR, Smalley DL. The immunopathology of siliconosis. History, clinical presentation, and relation to silicosis and the chemistry of silicon and silicone. Immunol Res. 1998;18:125\u201373.","journal-title":"Immunol Res"},{"key":"63_CR37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/153537020623100506","volume":"231","author":"T Otsuki","year":"2006","unstructured":"Otsuki T, Miura Y, Nishimura Y, Hyodoh F, Takata A, Kusaka M, et al. Alterations of Fas and Fas-related molecules in patients with silicosis. Exp Biol Med (Maywood). 2006;231:522\u201333.","journal-title":"Exp Biol Med (Maywood)"},{"key":"63_CR38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF02591635","volume":"21","author":"S Romagnani","year":"1991","unstructured":"Romagnani S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res. 1991;21:152\u20138.","journal-title":"Int J Clin Lab Res"},{"key":"63_CR39","doi-asserted-by":"crossref","unstructured":"Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev. 1996:532\u201362.","DOI":"10.1128\/CMR.9.4.532"},{"key":"63_CR40","first-page":"1111","volume":"52","author":"A Caplan","year":"1959","unstructured":"Caplan A. Rheumatoid disease and pneumoconiosis (Caplan\u2019s syndrome). Proc R Soc Med. 1959;52:1111\u20133.","journal-title":"Proc R Soc Med"},{"key":"63_CR41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-55-4-667","volume":"55","author":"WK Morgan","year":"1961","unstructured":"Morgan WK. Caplan\u2019s syndrome, An interesting clinico-pathological occurrence. Ann Intern Med. 1961;55:667\u201372.","journal-title":"Ann Intern Med"},{"key":"63_CR42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/thx.17.3.205","volume":"17","author":"A Caplan","year":"1962","unstructured":"Caplan A, Payne RB, Withey JL. A broader concept of Caplan\u2019s syndrome related to rheumatoid factors. Thorax. 1962;17:205\u201312.","journal-title":"Thorax"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.imlet.2004.11.005","volume":"98","author":"P Wu","year":"2005","unstructured":"Wu P, Hyodoh F, Hatayama T, Sakaguchi H, Hatada S, Miura Y, et al. Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos\/chrysotile-A. Immunol Lett. 2005;98:145\u201352.","journal-title":"Immunol Lett"},{"key":"63_CR44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/039463200601900212","volume":"19","author":"P Wu","year":"2006","unstructured":"Wu P, Miura Y, Hyodoh F, Nishimura Y, Hatayama T, Hatada S, et al. Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients. Int J Immunopathol Pharmacol. 2006;19:357\u201368.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"63_CR45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/intimm\/dxh366","volume":"18","author":"S Chen","year":"2006","unstructured":"Chen S, Ishii N, Ine S, Ikeda S, Fujimura T, Ndhlovu LC, et al. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int Immunol. 2006;18:269\u201377.","journal-title":"Int Immunol"},{"key":"63_CR46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1532\/IJG97.06002","volume":"84","author":"Y Matsubara","year":"2006","unstructured":"Matsubara Y, Hori T, Morita R, Sakaguchi S, Uchiyama T. Delineation of immunoregulatory properties of adult T-cell leukemia cells. Int J Hematol. 2006;84:63\u20139.","journal-title":"Int J Hematol"},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1349-7006.2007.00646.x","volume":"99","author":"T Shimauchi","year":"2008","unstructured":"Shimauchi T, Kabashima K, Tokura Y. Adult T-cell leukemia\/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells. Cancer Sci. 2008;99:98\u2013106.","journal-title":"Cancer Sci"},{"key":"63_CR48","doi-asserted-by":"crossref","unstructured":"Abe M, Uchihashi K, Kazuto T, Osaka A, Yanagihara K, Tsukasaki K, et al. Foxp3 expression on normal and leukemic CD4(+)D25(+)T-cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells. Eur J Haematol. 2008, 28 May [Epub ahead of print].","DOI":"10.1111\/j.1600-0609.2008.01105.x"},{"key":"63_CR49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0273-2300(91)90018-Q","volume":"13","author":"EB Ilgren","year":"1991","unstructured":"Ilgren EB, Wagner JC. Background incidence of mesothelioma: animal and human evidence. Regul Toxicol Pharmacol. 1991;13:133\u201349.","journal-title":"Regul Toxicol Pharmacol"},{"key":"63_CR50","first-page":"718","volume":"34","author":"BP Lanphear","year":"1992","unstructured":"Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med. 1992;34:718\u201321.","journal-title":"J Occup Med"},{"key":"63_CR51","first-page":"683","volume":"75","author":"KM O\u2019Reilly","year":"2007","unstructured":"O\u2019Reilly KM, Mclaughlin AM, Beckett WS, Sime PJ. Asbestos-related lung disease. Am Fam Physician. 2007;75:683\u20138.","journal-title":"Am Fam Physician"},{"key":"63_CR52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12026-007-0060-9","volume":"40","author":"SJ Burgess","year":"2008","unstructured":"Burgess SJ, Maasho K, Masilamani M, Narayanan S, Borrego F, Coligan JE. The NKG2D receptor: immunobiology and clinical implications. Immunol Res. 2008;40:18\u201334.","journal-title":"Immunol Res"},{"key":"63_CR53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9:503\u201310.","journal-title":"Nat Immunol"},{"key":"63_CR54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.semcancer.2007.06.008","volume":"17","author":"MF Mescher","year":"2007","unstructured":"Mescher MF, Popescu FE, Gerner M, Hammerbeck CD, Curtsinger JM. Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors. Semin Cancer Biol. 2007;17:299\u2013308.","journal-title":"Semin Cancer Biol"},{"issue":"1\u20133","key":"63_CR55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/IR:36:1:137","volume":"36","author":"P Kalinski","year":"2006","unstructured":"Kalinski P, Nakamura Y, Watchmaker P, Giermasz A, Muthuswamy R, Mailliard RB. Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines. Immunol Res. 2006;36(1\u20133):137\u201346.","journal-title":"Immunol Res"},{"key":"63_CR56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1615\/CritRevImmunol.v27.i6.20","volume":"27","author":"C Hong","year":"2007","unstructured":"Hong C, Park SH. Application of natural killer T cells in antitumor immunotherapy. Crit Rev Immunol. 2007;27:511\u201325.","journal-title":"Crit Rev Immunol"},{"key":"63_CR57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.it.2007.05.008","volume":"28","author":"M Terabe","year":"2007","unstructured":"Terabe M, Berzofsky JA. NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis. Trends Immunol. 2007;28:491\u20136.","journal-title":"Trends Immunol"},{"key":"63_CR58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00043764-200001000-00007","volume":"42","author":"P Froom","year":"2000","unstructured":"Froom P, Lahat N, Kristal-Boneh E, Cohen C, Lerman Y, Ribak J. Circulating natural killer cells in retired asbestos cement workers. J Occup Environ Med. 2000;42:19\u201324.","journal-title":"J Occup Environ Med"},{"key":"63_CR59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/acprof:oso\/9780195178692.003.0009","volume-title":"Asbestos and its diseases","author":"JE Craighead","year":"2008","unstructured":"Craighead JE. Nonthracic cancers possibly resulting from asbestos exposure. In: Craighead JE, Gibbs AR, editors. Asbestos and its diseases. New York: Oxford University Press; 2008. p. 230\u201352."}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12199-008-0063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12199-008-0063-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12199-008-0063-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T19:32:56Z","timestamp":1710185576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12199-008-0063-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,18]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s12199-008-0063-8","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"value":"1342-078X","type":"print"},{"value":"1347-4715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,18]]}}}